Status:
RECRUITING
ECMM Candida Registry - CandiReg
Lead Sponsor:
University of Cologne
Conditions:
Invasive Candidiases
Eligibility:
All Genders
Brief Summary
The objective of the European Confederation of Medical Mycology - ECMM Candida Registry (CandiReg) is to overcome the lack of knowledge on epidemiology, clinical course, and molecular characteristics ...
Detailed Description
The specific objectives are: To describe the global incidence of invasive Candida infection To monitor trends globally and locally over time To define patient risk groups To assess antifungal resista...
Eligibility Criteria
Inclusion
- Cultural, histopathological, antigen or DNA evidence of invasive fungal infection with Candida species.
- Hepatosplenic candidiasis with signs of disseminated Candida infection without culture, histological or microscopic evidence
- Case control
- Matching procedure for controls:
- In part, controls will be included at the same hospitals that include cases (i.e. each one control per case, both in the same hospital).
- Controls will be matched by demographics, underlying diseases and risk factors as well as duration of hospitalization
Exclusion
- \- Colonization or other non-invasive infection, including superficial skin infections, candiduria without dissemination or Candida spp. in stool.
Key Trial Info
Start Date :
January 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03450005
Start Date
January 18 2018
End Date
December 31 2026
Last Update
December 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Cologne
Cologne, North Rhine-Westphalia, Germany, 50937